(Q38036777)

27 August 2017

Relationship between sleep disorders and the risk for developing type 2 diabetes mellitus (English)

1 reference

27 August 2017

1 reference

Simona Ioja

1

1 reference

27 August 2017

Ian D Weir

series ordinal

2

1 reference

27 August 2017

Nancy J Rennert

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

27 August 2017

Postgraduate Medicine

1 reference

27 August 2017

124

1 reference

27 August 2017

4

1 reference

27 August 2017

119-129

1 reference

The epidemiology of adult obstructive sleep apnea

27 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep-disordered breathing and mortality: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Obstructive sleep apnea is independently associated with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Association of sleep apnea and type II diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Obstructive sleep apnea as a risk factor for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Obstructive sleep apnoea is associated with diabetes in sleepy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Insulin resistance and daytime sleepiness in patients with sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Effects of sleep fragmentation on glucose metabolism in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Disorders of glucose metabolism in sleep-disordered breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep, sleep-disordered breathing and metabolic consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Obstructive sleep apnea and type 2 diabetes: interacting epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

ERS Meeting Report. Metabolic aspects of obstructive sleep apnoea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Alterations in Glucose Disposal in Sleep-disordered Breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure--a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

The economic impact of obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Cardiovascular and metabolic effects of CPAP in obese males with OSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Do sleep disorders and associated treatments impact glucose metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Standards of medical care in diabetes--2012

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Association of sleep time with diabetes mellitus and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

A prospective study of self-reported sleep duration and incident diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women - The FIN-D2D survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Impact of sleep debt on metabolic and endocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

The metabolic consequences of sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep duration and the risk of diabetes mellitus: epidemiologic evidence and pathophysiologic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Shift work and chronic disease: the epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Incidence of metabolic syndrome among night-shift healthcare workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Persistent rotating shift-work exposure accelerates development of metabolic syndrome among middle-aged female employees: a five-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Shift work aggravates metabolic syndrome development among early-middle-aged males with elevated ALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Atypical work hours and metabolic syndrome among police officers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Markers of insulin resistance in day and shift workers aged 30-59 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep complaints and restless legs syndrome in adult type 2 diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Restless legs syndrome and quality of sleep in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Sleep quality and quality of life in adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.07.2573

21 January 2018

Identifiers

DOI

10.3810/PGM.2012.07.2573

1 reference

27 August 2017

1 reference